BACKGROUND: To determine the relationship between eosinophil-to-monocyte ratio (EMR) on admission and one-month and long-term all-cause mortality in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (P-PCI). METHODS: A total of 426 consecutive STEMI patients treated with P-PCI were enrolled and categorized in terms of tertiles of EMR on admission between September 2015 and October 2017. Final follow-up for long-term outcomes was January 2017. RESULTS: As EMR decreased, all-cause mortality at 1 month (mean, 29.5±3.5 days) and at mean 14.1±7.8 months follow-up increased (P=0.012, P=0.003, respectively). Kaplan-Meier survival curve analysis showed EMR was associated with 1-month and long-term all-cause mortality (P=0.048, P=0.015, respectively). In multivariate Cox proportional hazards analysis, EMR was independently associated with one-month and long-term mortality (hazard ratio =0.097; 95% CI, 0.010-0.899; P=0.04; hazard ration =0.176; 95% CI, 0.045-0.694; P=0.013). The area under the curve of EMR for the prediction of 1-month and long-term total mortality in receiver operating characteristic analysis was 0.789 (95% CI, 0.658-0.921; P=0.003) and 0.752 (95% CI, 0.619-0.884; P=0.001), respectively. CONCLUSIONS: EMR on admission was independently correlated with 1-month and long-term all-cause mortality in STEMI patients undergoing P-PCI, suggesting EMR as a potential simple, useful, and inexpensive index for risk stratification of STEMI patients.
BACKGROUND: To determine the relationship between eosinophil-to-monocyte ratio (EMR) on admission and one-month and long-term all-cause mortality in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (P-PCI). METHODS: A total of 426 consecutive STEMI patients treated with P-PCI were enrolled and categorized in terms of tertiles of EMR on admission between September 2015 and October 2017. Final follow-up for long-term outcomes was January 2017. RESULTS: As EMR decreased, all-cause mortality at 1 month (mean, 29.5±3.5 days) and at mean 14.1±7.8 months follow-up increased (P=0.012, P=0.003, respectively). Kaplan-Meier survival curve analysis showed EMR was associated with 1-month and long-term all-cause mortality (P=0.048, P=0.015, respectively). In multivariate Cox proportional hazards analysis, EMR was independently associated with one-month and long-term mortality (hazard ratio =0.097; 95% CI, 0.010-0.899; P=0.04; hazard ration =0.176; 95% CI, 0.045-0.694; P=0.013). The area under the curve of EMR for the prediction of 1-month and long-term total mortality in receiver operating characteristic analysis was 0.789 (95% CI, 0.658-0.921; P=0.003) and 0.752 (95% CI, 0.619-0.884; P=0.001), respectively. CONCLUSIONS: EMR on admission was independently correlated with 1-month and long-term all-cause mortality in STEMI patients undergoing P-PCI, suggesting EMR as a potential simple, useful, and inexpensive index for risk stratification of STEMI patients.
Authors: Crystel M Gijsberts; Guilielmus H J M Ellenbroek; Maarten J Ten Berg; Albert Huisman; Wouter W van Solinge; Carolyn S Lam; Folkert W Asselbergs; Hester M den Ruijter; Gerard Pasterkamp; Imo E Hoefer; Dominique P de Kleijn Journal: Am J Cardiol Date: 2017-06-29 Impact factor: 2.778
Authors: David Carrick; Caroline Haig; Sam Rauhalammi; Nadeem Ahmed; Ify Mordi; Margaret McEntegart; Mark C Petrie; Hany Eteiba; Mitchell Lindsay; Stuart Watkins; Stuart Hood; Andrew Davie; Ahmed Mahrous; Naveed Sattar; Paul Welsh; Niko Tzemos; Aleksandra Radjenovic; Ian Ford; Keith G Oldroyd; Colin Berry Journal: JACC Cardiovasc Imaging Date: 2015-06-17
Authors: James Tankel; Alexander Calderone; Jose Luis Ramirez Garcia-Luna; Carmen L Mueller; Sarah Najmeh; Jonathan Spicer; David Mulder; Lorenzo Ferri; Jonathan Cools-Lartigue Journal: Ann Surg Oncol Date: 2022-04-04 Impact factor: 5.344
Authors: Femke M Prins; M Abdullah Said; Yordi J van de Vegte; Niek Verweij; Hilde E Groot; Pim van der Harst Journal: Genes (Basel) Date: 2019-11-07 Impact factor: 4.096
Authors: Raquel Del Toro; Isabel Galeano-Otero; Elisa Bevilacqua; Francisco Guerrero-Márquez; Debora Falcon; Agustín Guisado-Rasco; Luis Díaz-de la Llera; Gonzalo Barón-Esquivias; Tarik Smani; Antonio Ordóñez-Fernández Journal: Front Cardiovasc Med Date: 2022-03-24